Emergency treatments if get COVID-19 symptoms
Take at home within 5 days of getting COVID-19 symptoms
| Vitamin D | molnupiravir (Merck) | |
| Cost | $1 | $700 |
| Availability | Over the counter | Prescription (if approved) |
| Experience with medication |
>100,000,000 people over 70 years |
400 people in an RCT over a few months |
| Experience with the compound |
500 million years | months with COVID |
| How often to take | once | twice a day for 5 days |
| Reduced risk of hospitalization |
>2X | 2X |
| Vaccinated? | does not matter | trial participants were UNvaccinated |
| FYI on names | Sometimes called Vitamin D Hammer |
Name derived from Thor's Hammer -Mjölnir |
| Health problems fought |
COVID-19 coronavirus, enveloped virus, colds, flu, etc |
COVID-19 |
Vitamin D: 200,000 IU (4 capsules of 50,000 IU each)
page is under construction in VitaminDWiki
Merck says a trial shows it has produced the first effective antiviral pill for Covid NYT Oct 1, 2021 📄 PDF
Merck’s experimental pill to treat covid-19 cuts risk of hospitalization and death in half, the pharmaceutical company reports Washington Post, Oct 1. 2021
trial participants "had to start the drug regimen within five days of symptom onset and be un vaccinated."
" ... molnupiravir works by introducing genetic errors that garble the coronavirus’s genetic code. That means it may be more resistant to mutation, and may even work on other coronaviruses or RNA viruses."
Pfizer is also developing an oral antiviral drug, and announced this week it was initiating a later-stage clinical trial testing the drug’s ability to prevent illness in people exposed to the coronavirus."
MERCK SELLS FEDERALLY FINANCED COVID PILL TO U.S. FOR 40 TIMES WHAT IT COSTS TO MAKE The Intercept Oct 5, 2021
"The Covid-19 treatment molnupiravir was developed using funding from the National Institutes of Health and the Department of Defense."
"Like the vast majority of medicines on the market, molnupiravir — which was originally investigated as a possible treatment for Venezuelan equine encephalitis — was developed using government funds"
"Indian companies are planning to price the drug at less than $12 for a five-day course"
DoctorMurray.com email Oct 7, 2021 on Quercetin being better than molnupiravir
"Quercetin is something else that I have highlighted as a treatment for COVID based on not only detailed studies showing an antiviral effect, but also clinical results from two trials."
"These two published human clinical studies with an enhanced form of quercetin for improved absorption both produced better results than molnupiravir."
"Quercetin cut hospitalization by 68%. And when patients did have to be hospitalized, the average stay was 6.77 days in the standard care group but only 1.57 days in the quercetin group. Quercetin not only reduced mortality by 100%, but also had a 100% success rate in preventing patients from entering the ICU."
In clinical trials in 2019 to fight Influenza and some coronaviruses
7 Symptoms predictive of COVID-19 (from 1,000,000 in UK) – Oct 2021
Loss of taste, Loss of smell. Fever. New persistent cough. Chills, Appetite loss. Muscle aches
COVID-19 treated by Vitamin D - studies, reports, videos
- {include}
Mortality and Virus studies
{category}
Vitamin D meta-analyses for Virus
{category}

- The above image is automatically updated
Early treatment (as of Oct 9, 2021)
